AKER - Akers Biosciences, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue2,960.9122,115.054,427.174
Cost of Revenue1,083.087950.7921,175.232
Gross Profit1,877.8251,164.2583,251.942
Operating Expenses
Research Development1,188.8681,406.895916.308
Selling General and Administrative5,146.0936,572.8025,281.183
Non Recurring-1,299.6092,630.0852,630.085
Others171.108236.706258.572
Total Operating Expenses5,206.4610,846.488-
Operating Income or Loss-3,328.635-9,682.23-3,204.121
Income from Continuing Operations
Total Other Income/Expenses Net25.097100.97376.954
Earnings Before Interest and Taxes-3,303.538-9,581.257-3,127.167
Interest Expense---
Income Before Tax-3,303.538-9,581.257-3,127.167
Income Tax Expense--269.344-
Minority Interest---
Net Income From Continuing Ops-3,303.538-9,311.913-3,127.167
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-3,303.538-9,311.913-3,127.167
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-3,303.538-9,311.913-3,142.96